Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 6.00 (0.735%)
Market Cap: £774.44m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM Update

16 Jan 2009 07:00

RNS Number : 7491L
Polar Capital Holdings PLC
16 January 2009
 



16 January 2009

Polar Capital Holdings plc

AUM Update

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

Group AUM (unaudited)

As at 31 December 2008 Group AUM has fallen 22% since 31 March 2008 to US$2.45bn

The table below sets out the Group's AUM as at 31 December 2008 and the movements experienced in the 9 month period since 31 March 2008:

AUM movement

9 months to 31 Dec 2008

Long

$m

Hedge

$m

Advisory

$m

Total

$m

As at 3March 2008

$1,016m

$2,005m

$122m

$3,143m

Performance and currency movements

($254)m

($150)m

($23)m

($427)m

Net subscriptions/(redemptions) from ongoing businesses

$49m

$94m

($62)m

$81m

Outflows from closed funds

nil

($347)m

nil

($347)m 

Total AUM at 31 Dec 2008

$811m

$1,602m

$37m

$2,450m

Net performance fees (unaudited)

The table below sets out the position relating to net performance fees earned and accrued in the first nine months of the year to 31 March 2009:

Performance fees

net of manager allocations

9 months to

31 Dec 07

£m

Year to

31 Mar 08

(year end)

£m

9 months to

31 Dec 08

£m

Received 

£6.1m

£8.0m

£8.1m

Accrued but not yet earned in funds with year ends on or before the financial year end.

£2.0m

n/a

£1.6m

Total performance fees

£8.1m

£8.0m

£9.7m

Note that the analysis has been changed from the historic disclosure of gross performance fees to net performance fees after the deduction of manager's interests. It is felt that the new basis is more helpful providing greater transparency on performance fee income.

Comment

Despite the encouraging net inflows received into Polar Capital's funds in the first nine months of its financial year the affect of the maelstrom that has struck the industry in the final quarter of 2008 will produce an expected $500m of redemptions in the Group's final quarter. In addition to these redemptions the recent announcement of the resignation of Julian Barnett will account for a further $400m of outflows as the Paragon Fund is wound up. Investors in the Paragon Fund will be given the opportunity to reinvest in Polar Capital's other hedge funds.

Against this backdrop the Group is fortunate that five of its hedge funds are in a strong position to attract assets, with four bucking the industry trend and making money in 2008. In addition the Group has a portfolio of long only products that have also outperformed their respective benchmarks, some funds to a significant degree. This pedigree of investment performance combined as it is with the depth and breadth of Polar Capital's sales, risk, operational and regulatory support puts the Group in strong position to attract assets, as and when the environment improves, into its range of long only and hedge products as it looks out into calendar year 2009.

For further information please contact:

Polar Capital

Mark Kary John Mansell

+44 (0)20 7227 2700

Numis Securities

Lee Aston

Charles Farquhar

+44 (0)20 7260 1000

Financial Dynamics 

Ed Gascoigne-Pees

Georgina Turner

+44 (0)20 7269 7132

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAAFSFEDNEAE
Date   Source Headline
4th Feb 20199:43 amRNSBlock listing Interim Review
1st Feb 201911:41 amRNSTotal Voting Rights
29th Jan 20194:41 pmRNSSecond Price Monitoring Extn
29th Jan 20194:35 pmRNSPrice Monitoring Extension
28th Jan 20195:45 pmRNSIssue of Equity
28th Jan 20195:30 pmRNSDirector/PDMR Shareholding
10th Jan 201910:19 amRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSAUM Update
2nd Jan 20199:49 amRNSTotal Voting Rights
12th Dec 20184:00 pmRNSIssue of Equity
27th Nov 20184:40 pmRNSSecond Price Monitoring Extn
27th Nov 20184:35 pmRNSPrice Monitoring Extension
26th Nov 20187:00 amRNSUnaudited Interim Results
22nd Nov 20185:00 pmRNSDirectorate Change
5th Nov 20187:01 amRNSNotice of Results
5th Nov 20187:00 amRNSChange of Nominated Adviser and Broker
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20185:26 pmRNSIssue of Equity
24th Oct 20184:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:49 pmRNSIssue of Equity
15th Oct 201812:38 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
12th Oct 20182:52 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
11th Oct 20184:42 pmRNSIssue of Equity
11th Oct 20187:01 amRNSCrystallisation of business unit & issue of shares
11th Oct 20187:00 amRNSAUM Update
3rd Oct 201810:24 amRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
19th Sep 201811:52 amRNSForm 8.3 - Jardine Lloyd Thompson Group
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
17th Aug 20189:27 amRNSDirectorate Change
6th Aug 20187:00 amRNSBlock listing Interim Review
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding
12th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
12th Jul 20187:00 amRNSAuM Update
11th Jul 201811:06 amRNSForm 8.3 - Consort Medical Plc
3rd Jul 20186:27 pmRNSHolding(s) in Company
3rd Jul 20186:20 pmRNSIssue of Equity
3rd Jul 201812:07 pmRNSForm 8.3 - Consort Medical Plc
2nd Jul 201810:23 amRNSTotal Voting Rights
29th Jun 20187:00 amRNSBlock Listing Application
28th Jun 20185:55 pmRNSAnnual Financial Report
25th Jun 20187:00 amRNSGroup Audited Results for year ended 31 March 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.